By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
药物开发及商业化阶段的产品和服务1.66B84.03%
药物研究阶段的产品和服务308.76M15.64%
Other6.57M0.33%
By Industry
Currency:CNY
2025/FY
Stock NameRevenueRatio
药物研发与生产相关业务1.97B100.00%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
Abroad1.43B72.66%
Domestic539.88M27.34%
